Chronic Pain — 09 April 2013

bigstock-Genetic-Code-3335806By Richard Lenti

Chemotherapy-induced peripheral neuropathy is not only painful – it’s hard to predict — affecting up to 40 percent of cancer patients who undergo treatment.  But now researchers at the Mayo Clinic say they have discovered gene variations that could someday help doctors identify which patients are more susceptible to the often debilitating condition.

In what’s being described as the first of its kind study to explore such a large swath of the human genome, three genes have been singled out as predictors of chemotherapy side effects. It’s a discovery that may enable physicians to improve cancer treatment by individualizing a patient’s care to their risk for a particular chemotherapy side effect.

Read more at National Pain Report.


About Author

Richard Lenti

Richard Lenti has worked as a news writer for the last 20 years at various television stations in Los Angeles. He is a Golden Mike winner and a graduate of California State University, Fresno. With roots in print journalism, Richard is excited to be “published” once again; having people read his work as opposed to having it read to them. As a freelance writer his work has appeared in the Easy Reader, L.A. Jazz Scene, Irrigation and Green Industry, and the KCAL 9 Online website.

(0) Readers Comments

Comments are closed.